Freyr is a leading, niche, full-service global Regulatory Solutions and Services Company supporting, Large, Mid and Small global Life sciences companies, (Pharmaceutical |Generics | Medical Device | Biotechnology | Biosimilar | Consumer Healthcare | Cosmetics) in their entire Regulatory value-chain; ranging from Regulatory Strategy, Intelligence, Dossiers, Submissions etc. to Post- Approval / Legacy Product Maintenance, Labeling, Artwork Change Management and other related functions. Freyr is one of the few global companies to have pioneered specialized Centers of Excellence (CoEs) exclusively focusing on the entire Regulatory value-chain which are supported by rapidly growing global teams of 550+ Regulatory Professionals. Freyr is a strategic Regulatory solutions and services partner to 250+ clients inclusive of: 07 Forbes Global Top 10, Pharma Companies - 05 Forbes Global Top 6, Biotech Companies - 05 Forbes Global Top 7, Consumer Healthcare Companies - 06 Top 15 and 20+, Generic Companies - 30+ Innovator Pharma Companies - 10+ Bio-Tech / Bio-Similar Companies - 10+ CROs / Consulting Companies - 30+ Medical Device Companies - 35+ Consumer Companies (Cosmetics / Nutraceuticals ) - 50+ Generic Companies/API Manufacturers Specialties Regulatory Consulting & Strategy, Regulatory Operations & Affairs, Regulatory Software Solutions, Regulatory Information & Intelligence, Global Regulatory Responsibility Services, Regulatory Publishing & Submission, Regulatory Medical Writing, IDMP, Medical Devices Regulatory Services, Regulatory Artwork & Labeling, CMC, and UDI